It was indeed revealed that the R200K mutation is a naturally occurring hotspot mutation in bladder cancer that causes transcriptional upregulation of YAP/TAZ and MRTF-A/B via a RHOGEF - RHOA GTPase cascade. This evidence concerns the gene RHOA and urinary bladder cancer.